Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1988 Dec;26(6):759–764. doi: 10.1111/j.1365-2125.1988.tb05316.x

Variability in response to nonsteroidal anti-inflammatory analgesics: evidence from controlled clinical therapeutic trial of flurbiprofen in rheumatoid arthritis.

S J Preston 1, M H Arnold 1, E M Beller 1, P M Brooks 1, W W Buchanan 1
PMCID: PMC1386592  PMID: 3242581

Abstract

1. A clinical trial was conducted with flurbiprofen 100 mg three times a day by mouth in rheumatoid arthritis to determine variability in response. 2. Forty patients entered the study, but only 32 completed it. Patients were treated with flurbiprofen on two occasions at a month's interval, each being preceded by a 3 day wash out period. Pain relief and a Ritchie articular index of joint tenderness was assessed at the beginning and end of each treatment period. 3. Flurbiprofen produced significant improvement in both pain relief and articular tenderness. No significant differences were observed between the two trial periods in the mean of these outcome measures. 4. No evidence was found to support the concept of responders and non-responders.

Full text

PDF
759

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aarons L., Grennan D. M., Rajapakse C., Brinkley J., Siddiqui M., Taylor L., Higham C. Anti-inflammatory (ibuprofen) drug therapy in rheumatoid arthritis--rate of response and lack of time dependency of plasma pharmacokinetics. Br J Clin Pharmacol. 1983 Mar;15(3):387–388. doi: 10.1111/j.1365-2125.1983.tb01517.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Abramson S., Edelson H., Kaplan H., Given W., Weissmann G. The neutrophil in rheumatoid arthritis: its role and the inhibition of its activation by nonsteroidal antiinflammatory drugs. Semin Arthritis Rheum. 1983 Aug;13(1 Suppl 1):148–153. doi: 10.1016/0049-0172(83)90035-5. [DOI] [PubMed] [Google Scholar]
  3. Baber N., Halliday L. D., van den Heuvel W. J., Walker R. W., Sibeon R., Keenan J. P., Littler T., Orme M. L. Indomethacin in rheumatoid arthritis: clinical effects, pharmacokinetics, and platelet studies in responders and nonresponders. Ann Rheum Dis. 1979 Apr;38(2):128–136. doi: 10.1136/ard.38.2.128. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bellamy N. Variance in NSAID studies: contribution of patient variance. Agents Actions Suppl. 1985;17:21–28. doi: 10.1007/978-3-0348-7720-6_2. [DOI] [PubMed] [Google Scholar]
  5. Capell H. A., Rennie J. A., Rooney P. J., Murdoch R. M., Hole D. J., Dick W. C., Buchanan W. W. Patient compliance: a novel method of testing non-steroidal antiinflammatory analgesics in rheumatoid arthritis. J Rheumatol. 1979 Sep-Oct;6(5):584–593. [PubMed] [Google Scholar]
  6. DIAGNOSTIC criteria for rheumatoid arthritis: 1958 revision by a committee of the American Rheumatism Association. Ann Rheum Dis. 1959 Mar;18(1):49–53. [PMC free article] [PubMed] [Google Scholar]
  7. Day R. O., Brooks P. M. Variations in response to non-steroidal anti-inflammatory drugs. Br J Clin Pharmacol. 1987 Jun;23(6):655–658. doi: 10.1111/j.1365-2125.1987.tb03098.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Day R. O., Furst D. E., Dromgoole S. H., Kamm B., Roe R., Paulus H. E. Relationship of serum naproxen concentration to efficacy in rheumatoid arthritis. Clin Pharmacol Ther. 1982 Jun;31(6):733–740. doi: 10.1038/clpt.1982.103. [DOI] [PubMed] [Google Scholar]
  9. Day R. O. Variability in response to NSAID. Agents Actions Suppl. 1985;17:15–19. doi: 10.1007/978-3-0348-7720-6_1. [DOI] [PubMed] [Google Scholar]
  10. Deodhar S. D., Dick W. C., Hodgkinson R., Buchanan W. W. Measurement of clinical response to anti-inflammatory drug therapy in rheumatoid arthritis. Q J Med. 1973 Apr;42(166):387–401. [PubMed] [Google Scholar]
  11. Dunagan F. M., McGill P. E., Kelman A. W., Whiting B. Quantitation of dose and concentration-effect relationships for fenclofenac in rheumatoid arthritis. Br J Clin Pharmacol. 1986 Apr;21(4):409–416. doi: 10.1111/j.1365-2125.1986.tb05215.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Ekstrand R., Alván G., L'e Orme M., Lewander R., Palmér L., Sarby B. Double-blind dose-response study of indomethacin in rheumatoid arthritis. Eur J Clin Pharmacol. 1980 Jun;17(6):437–442. doi: 10.1007/BF00570161. [DOI] [PubMed] [Google Scholar]
  13. Gall E. P., Caperton E. M., McComb J. E., Messner R., Multz C. V., O'Hanlan M., Willkens R. F. Clinical comparison of ibuprofen, fenoprofen calcium, naproxen and tolmetin sodium in rheumatoid arthritis. J Rheumatol. 1982 May-Jun;9(3):402–407. [PubMed] [Google Scholar]
  14. Grennan D. M., Aarons L., Siddiqui M., Richards M., Thompson R., Higham C. Dose-response study with ibuprofen in rheumatoid arthritis: clinical and pharmacokinetic findings. Br J Clin Pharmacol. 1983 Mar;15(3):311–316. doi: 10.1111/j.1365-2125.1983.tb01504.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Huskisson E. C. Simple analgesics for arthritis. Br Med J. 1974 Oct 26;4(5938):196–200. doi: 10.1136/bmj.4.5938.196. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Huskisson E. C., Woolf D. L., Balme H. W., Scott J., Franklin S. Four new anti-inflammatory drugs: responses and variations. Br Med J. 1976 May 1;1(6017):1048–1049. doi: 10.1136/bmj.1.6017.1048. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Ku E. C., Kothari H., Lee W., Kimble E. F., Liauw L. H. Effects of diclofenac sodium on arachidonic acid metabolism. Agents Actions Suppl. 1985;17:189–193. doi: 10.1007/978-3-0348-7720-6_23. [DOI] [PubMed] [Google Scholar]
  18. Lanza F. L., Royer G. L., Jr, Nelson R. S., Chen T. T., Seckman C. E., Rack M. F. The effects of ibuprofen, indomethacin, aspirin, naproxen, and placebo on the gastric mucosa of normal volunteers: a gastroscopic and photographic study. Dig Dis Sci. 1979 Nov;24(11):823–828. doi: 10.1007/BF01324896. [DOI] [PubMed] [Google Scholar]
  19. Lee P., Anderson J. A., Miller J., Webb J., Buchanan W. W. Evaluation of analgesic action and efficacy of antirheumatic drugs. Study of 10 drugs in 684 patients with rheumatoid arthritis. J Rheumatol. 1976 Sep;3(3):283–294. [PubMed] [Google Scholar]
  20. Lee P., Webb J., Anderson J., Buchanan W. W. Method for assessing therapeutic potential of anti-inflammatory antirheumatic drugs in rheumatoid arthritis. Br Med J. 1973 Jun 23;2(5868):685–688. doi: 10.1136/bmj.2.5868.685. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. McGill P. E. NSAID-plasma concentration monitoring--optimizing treatment of R.A. Agents Actions Suppl. 1985;17:157–161. doi: 10.1007/978-3-0348-7720-6_19. [DOI] [PubMed] [Google Scholar]
  22. Orme M. L. Plasma concentrations and therapeutic effect of anti-inflammatory and anti-rheumatic drugs. Pharmacol Ther. 1982;16(2):167–180. doi: 10.1016/0163-7258(82)90052-3. [DOI] [PubMed] [Google Scholar]
  23. Orme M., Baber N., Keenan J., Halliday L., Sibeon R., Littler T. Pharmacokinetics and biochemical effects in responders and non-responders to non-steroidal anti-inflammatory drugs. Scand J Rheumatol Suppl. 1981;39:19–27. doi: 10.3109/03009748109095330. [DOI] [PubMed] [Google Scholar]
  24. Ritchie D. M., Boyle J. A., McInnes J. M., Jasani M. K., Dalakos T. G., Grieveson P., Buchanan W. W. Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. Q J Med. 1968 Jul;37(147):393–406. [PubMed] [Google Scholar]
  25. Scott D. L., Roden S., Marshall T., Kendall M. J. Variations in responses to non-steroidal anti-inflammatory drugs. Br J Clin Pharmacol. 1982 Nov;14(5):691–694. doi: 10.1111/j.1365-2125.1982.tb04958.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Verbeeck R. K., Blackburn J. L., Loewen G. R. Clinical pharmacokinetics of non-steroidal anti-inflammatory drugs. Clin Pharmacokinet. 1983 Jul-Aug;8(4):297–331. doi: 10.2165/00003088-198308040-00003. [DOI] [PubMed] [Google Scholar]
  27. Wasner C., Britton M. C., Kraines R. G., Kaye R. L., Bobrove A. M., Fries J. F. Nonsteroidal anti-inflammatory agents in rheumatoid arthritis and ankylosing spondylitis. JAMA. 1981 Nov 13;246(19):2168–2172. [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES